194 related articles for article (PubMed ID: 15238080)
21. The mouse immune response to human fibrinogen reveals an autoimmune component against mouse fibrinogen.
Rubin B; Matron C
Cell Immunol; 2005 Jan; 233(1):41-52. PubMed ID: 15876427
[TBL] [Abstract][Full Text] [Related]
22. Mice lacking endogenous major histocompatibility complex class II develop arthritis resembling psoriatic arthritis at an advanced age.
Bárdos T; Zhang J; Mikecz K; David CS; Glant TT
Arthritis Rheum; 2002 Sep; 46(9):2465-75. PubMed ID: 12355495
[TBL] [Abstract][Full Text] [Related]
23. Major histocompatibility complex controls susceptibility and dominant inheritance, but not the severity of the disease in mouse models of rheumatoid arthritis.
Adarichev VA; Bárdos T; Christodoulou S; T Phillips M; Mikecz K; Glant TT
Immunogenetics; 2002 Jun; 54(3):184-92. PubMed ID: 12073147
[TBL] [Abstract][Full Text] [Related]
24. The influence of MHC class II molecules containing the rheumatoid arthritis shared epitope on the immune response to aggrecan G1 and its peptides.
Brintnell W; Bell DA; Hill JA; Jevnikar AM; Sette A; Sidney J; Doege K; Cairns E
Scand J Immunol; 2007 May; 65(5):444-52. PubMed ID: 17444955
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between HLA-DR4/1 subtypes and T cell response to influenza virus hemagglutinin or anti-HA308-317 antibodies in rheumatoid arthritis].
Li X; Li R; Li ZG
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1881-3. PubMed ID: 19039998
[TBL] [Abstract][Full Text] [Related]
26. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.
Auger I; Sebbag M; Vincent C; Balandraud N; Guis S; Nogueira L; Svensson B; Cantagrel A; Serre G; Roudier J
Arthritis Rheum; 2005 Nov; 52(11):3424-32. PubMed ID: 16255019
[TBL] [Abstract][Full Text] [Related]
27. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis.
Liao F; Li Z; Wang Y; Shi B; Gong Z; Cheng X
Med Hypotheses; 2009 Jun; 72(6):732-5. PubMed ID: 19246161
[TBL] [Abstract][Full Text] [Related]
28. Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.
Cantaert T; Teitsma C; Tak PP; Baeten D
Arthritis Rheum; 2013 Apr; 65(4):939-48. PubMed ID: 23280233
[TBL] [Abstract][Full Text] [Related]
29. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.
Hill JA; Southwood S; Sette A; Jevnikar AM; Bell DA; Cairns E
J Immunol; 2003 Jul; 171(2):538-41. PubMed ID: 12847215
[TBL] [Abstract][Full Text] [Related]
30. Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper.
Ebringer A; Rashid T; Wilson C
Autoimmun Rev; 2010 Feb; 9(4):216-23. PubMed ID: 19895906
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach.
Matsuo K; Xiang Y; Nakamura H; Masuko K; Yudoh K; Noyori K; Nishioka K; Saito T; Kato T
Arthritis Res Ther; 2006; 8(6):R175. PubMed ID: 17125526
[TBL] [Abstract][Full Text] [Related]
32. Citrullination in extra-articular manifestations of rheumatoid arthritis.
Bongartz T; Cantaert T; Atkins SR; Harle P; Myers JL; Turesson C; Ryu JH; Baeten D; Matteson EL
Rheumatology (Oxford); 2007 Jan; 46(1):70-5. PubMed ID: 16782731
[TBL] [Abstract][Full Text] [Related]
33. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis.
Lac P; Saunders S; Tutunea-Fatan E; Barra L; Bell DA; Cairns E
J Autoimmun; 2018 May; 89():75-81. PubMed ID: 29242008
[TBL] [Abstract][Full Text] [Related]
34. Peptide therapy for anti-CD4 autoimmunity in HIV-1 infection: toward the development of an autoimmune animal model.
Abulafia-Lapid R; Afentoulis M; Vandenbark AA
Vaccine; 2009 May; 27(25-26):3475-80. PubMed ID: 19200812
[TBL] [Abstract][Full Text] [Related]
35. Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids.
Takizawa Y; Suzuki A; Sawada T; Ohsaka M; Inoue T; Yamada R; Yamamoto K
Ann Rheum Dis; 2006 Aug; 65(8):1013-20. PubMed ID: 16449316
[TBL] [Abstract][Full Text] [Related]
36. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
Bang H; Egerer K; Gauliard A; Lüthke K; Rudolph PE; Fredenhagen G; Berg W; Feist E; Burmester GR
Arthritis Rheum; 2007 Aug; 56(8):2503-11. PubMed ID: 17665451
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of HLA-DR4 in the rheumatoid arthritis of a Chippewa band.
Harvey J; Arnett FC; Bias WB; Hsu SH; Stevens MB
J Rheumatol; 1981; 8(5):797-803. PubMed ID: 6975825
[TBL] [Abstract][Full Text] [Related]
38. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease.
Orbach H; Gilburd B; Brickman CM; Gerli R; Shoenfeld Y
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):892-3. PubMed ID: 12455175
[No Abstract] [Full Text] [Related]
39. Immune responsiveness against allogeneic platelet transfusions is determined by the recipient's major histocompatibility complex class II phenotype.
Sayeh E; Aslam R; Speck ER; Le-Tien H; Lazarus AH; Freedman J; Semple JW
Transfusion; 2004 Nov; 44(11):1572-8. PubMed ID: 15504162
[TBL] [Abstract][Full Text] [Related]
40. Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice.
Mangalam A; Rodriguez M; David C
Eur J Immunol; 2006 Dec; 36(12):3356-70. PubMed ID: 17125142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
